Current clinical use of intravenous fosfomycin in ICU patients in two European countries

Purpose In Europe, intravenous fosfomycin (IV) is used particularly in difficult-to-treat or complex infections, caused by both Gram-positive and Gram-negative pathogens including multidrug-resistant strains. Here, we investigated the efficacy and safety of intravenous fosfomycin under real-life con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection 2019-10, Vol.47 (5), p.827-836
Hauptverfasser:	Putensen, C., Ellger, B., Sakka, S. G., Weyland, A., Schmidt, K., Zoller, M., Weiler, N., Kindgen-Milles, D., Jaschinski, U., Weile, J., Lindau, S., Kieninger, M., Faltlhauser, A., Jung, N., Teschendorf, P., Adamzik, M., Gründling, M., Wahlers, T., Gerlach, H., Litty, F.-A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Adult Aged Anti-Bacterial Agents - administration & dosage Antibiotics Austria Bacteremia Bacterial diseases Bacterial infections Bacterial Infections - drug therapy Critical Illness E coli Family Medicine Female Fosfomycin Fosfomycin - administration & dosage General Practice Germany Hospitals Humans Infections Infectious Diseases Intensive care Intensive Care Units Internal Medicine Intravenous administration Klebsiella Male Medicine Medicine & Public Health Middle Aged Multidrug resistance Multidrug resistant organisms Original Paper Pathogens Patients Pneumonia Prospective Studies Sepsis Sepsis - drug therapy Sepsis - microbiology Therapy Treatment Outcome Ventilator-associated pneumonia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!